No connection

Search Results

ASGN

NEUTRAL
$51.04 Live
ASGN Incorporated · NYSE
Target $51.17 (+0.2%)
$39.25 52W Range $95.29

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$2.24B
P/E
17.48
ROE
7.2%
Profit margin
3.3%
Debt/Equity
0.68
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
68%
ASGN exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet fundamentals. The company trades near fair value based on the Graham Number of $52.86, with a current price of $51.04, while forward P/E of 10.26 suggests discounted earnings expectations. Despite healthy margins and a strong balance sheet (Current Ratio 1.99, Debt/Equity 0.68), revenue and earnings are contracting YoY (-1.90% and -17.90% respectively), offsetting valuation appeal. Analysts concur with a 'hold' rating and target price of $51.17, aligning closely with current levels.

Key Strengths

Strong Piotroski F-Score of 7/9 indicates high financial health and operational efficiency
Attractive valuation with current price below Graham Number ($51.04 vs $52.86)
Low forward P/E of 10.26 suggests undervaluation relative to earnings potential
Healthy liquidity profile with Current Ratio of 1.99 and Quick Ratio of 1.81
Debt/Equity of 0.68 is moderate and manageable within sector context

Key Risks

Negative YoY revenue growth (-1.90%) and declining earnings (-17.90%) signal weakening top-line momentum
Significant negative long-term price performance: -44.9% over 1Y and -43.5% over 5Y
Lack of Altman Z-Score prevents definitive assessment of bankruptcy risk
No dividend yield or payout history limits income appeal
Weak insider sentiment at 40/100 and zero insider transactions in last 6 months indicate lack of confidence
AI Fair Value Estimate
Based on comprehensive analysis
$52.86
+3.6% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
58
Moderate
Value
80
Future
45
Past
60
Health
85
Dividend
20
AI Verdict
Neutral with value appeal offset by growth concerns
Key drivers: Piotroski F-Score of 7 supports financial strength, Valuation appears attractive relative to Graham criteria, Declining earnings and revenue pressure future outlook, Analyst consensus aligned at hold with tight target
Confidence
70%
Value
80/100

Ref P/E, PEG, Graham Number

Positives
  • Current price ($51.04) below Graham Number ($52.86)
  • Forward P/E of 10.26 is low vs sector average (88.65)
  • Price/Sales of 0.56 indicates potential undervaluation
Watchpoints
  • Intrinsic Value (Growth-based) significantly lower at $20.44
Future
45/100

Ref Growth rates

Positives
  • Most recent Q/Q EPS growth of +12.0% shows short-term improvement
  • Analyst target implies minimal upside (+0.25%)
Watchpoints
  • YoY Revenue Growth: -1.90%
  • YoY Earnings Growth: -17.90%
  • Q/Q Earnings Growth: -19.80%
Past
60/100

Ref Historical trends

Positives
  • Consistent history of beating earnings estimates (23 out of 25 quarters)
  • Average earnings surprise of +7.1% over last 4 quarters
Watchpoints
  • 5Y price return of -43.5% reflects prolonged underperformance
  • Downward trend in EPS from $1.79 (2022) to $1.18 (2026 est)
Health
85/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 7/9 indicates strong financial health
  • Current Ratio of 1.99 and Quick Ratio of 1.81 reflect strong liquidity
  • Debt/Equity of 0.68 is within safe range
Watchpoints
  • Altman Z-Score not available, limiting full distress risk assessment
Dividend
20/100

Ref Yield, Payout

Positives
  • Payout ratio of 0.00% preserves capital for reinvestment
Watchpoints
  • No dividend yield or dividend history
  • Dividend Strength score of 0/100 indicates no income generation

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$51.04
Analyst Target
$51.17
Upside/Downside
+0.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ASGN and closest competitors.

Updated 2026-01-23
ASG
ASGN Incorporated
Primary
5Y
-43.5%
3Y
-42.0%
1Y
-44.9%
6M
-6.8%
1M
+2.4%
1W
+4.2%
AMB
Ambarella, Inc.
Peer
5Y
-54.5%
3Y
-33.1%
1Y
+0.2%
6M
-34.9%
1M
-21.8%
1W
-0.2%
EXT
Extreme Networks, Inc.
Peer
5Y
+75.3%
3Y
-15.1%
1Y
+52.2%
6M
-19.8%
1M
+17.6%
1W
+8.6%
FRS
Freshworks Inc.
Peer
5Y
-83.3%
3Y
-46.2%
1Y
-39.9%
6M
-30.4%
1M
-0.8%
1W
-4.6%
DAV
Dave Inc.
Peer
5Y
-47.2%
3Y
+2883.4%
1Y
+117.2%
6M
-18.4%
1M
-25.2%
1W
-4.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
17.48
Forward P/E
10.26
PEG Ratio
N/A
P/B Ratio
1.2
P/S Ratio
0.56
EV/Revenue
0.83
EV/EBITDA
8.91
Market Cap
$2.24B

Profitability

Profit margins and return metrics

Profit Margin 3.28%
Operating Margin 7.13%
Gross Margin 28.9%
ROE 7.25%
ROA 4.71%

Growth

Revenue and earnings growth rates

Revenue Growth -1.9%
Earnings Growth -17.9%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth -19.8%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.68
Moderate
Current Ratio
1.99
Good
Quick Ratio
1.81
Excellent
Cash/Share
$2.96

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-04
$N/A
2025-10-22
$1.31
+7.1% surprise
2025-07-23
$1.17
+8.1% surprise
2025-04-23
$0.92
-2.6% surprise

Technology Sector Comparison

Comparing ASGN against 565 companies in the Technology sector (45 bullish, 197 neutral, 323 bearish)
P/E Ratio
17.48
This Stock
vs
82.88
Sector Avg
-78.9% (Discount)
Return on Equity (ROE)
7.25%
This Stock
vs
-33.47%
Sector Avg
-121.6% (Below Avg)
Profit Margin
3.28%
This Stock
vs
-11.75%
Sector Avg
-127.9% (Weaker)
Debt to Equity
0.68
This Stock
vs
0.74
Sector Avg
-9.1% (Lower)
Revenue Growth
-1.9%
This Stock
vs
4383.21%
Sector Avg
-100.0% (Slower)
Current Ratio
1.99
This Stock
vs
3.59
Sector Avg
-44.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

CALLAGHAN BRIAN JOSEPH
Director
Stock Award
2026-01-02
4,500 shares · $209,970
SHERIDAN EDWIN A
Director
Stock Award
2026-01-02
4,500 shares · $209,970
LINDSTROM CAROL J
Director
Stock Award
2026-01-02
4,500 shares · $209,970
CUNNINGHAM ROSE
Officer
Stock Award
2026-01-02
3,750 shares · $174,975
OBERMAIER PATRICIA L
Director
Stock Award
2026-01-02
4,500 shares · $200,970
IYER SADASIVAM
President
Stock Award
2026-01-02
21,431 shares · $999,970
HAWTHORNE MARIA R
Director
Stock Award
2026-01-02
4,500 shares · $209,970
PAINTER JENNIFER HANKES
Officer
Stock Award
2026-01-02
13,930 shares · $649,974
MATIN ARSHAD
Director
Stock Award
2026-01-02
4,500 shares · $209,970
HOLMAN JONATHAN S
Director
Stock Award
2026-01-02
4,500 shares · $209,970
DYER JOSEPH WENDELL
Director
Stock Award
2026-01-02
4,500 shares · $209,970
PERRY MARIE L.
Chief Financial Officer
Stock Award
2026-01-02
18,752 shares · $874,968
FRANTZ MARK A
Director
Stock Award
2026-01-02
4,500 shares · $209,970
HANSON THEODORE S
Chief Executive Officer
Stock Award
2026-01-02
68,581 shares · $3,199,989
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
6 analysts
Wells Fargo
2026-01-21
Maintains
Equal-Weight Equal-Weight
Wells Fargo
2026-01-14
Maintains
Equal-Weight Equal-Weight
Truist Securities
2025-11-21
Maintains
Buy Buy
Wells Fargo
2025-11-21
Maintains
Equal-Weight Equal-Weight
UBS
2025-10-23
Maintains
Sell Sell
Truist Securities
2025-10-13
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning ASGN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile